Access the full text.
Sign up today, get DeepDyve free for 14 days.
Cristina Mendes de Oliveira, J. Fregnani, L. Villa (2019)
HPV Vaccine: Updates and HighlightsActa Cytologica, 63
S. Sanjosé, M. Brotons, M. Pavón (2017)
The natural history of human papillomavirus infection.Best practice & research. Clinical obstetrics & gynaecology, 47
M. Karimi-Zarchi, A. Tabatabaie, Ali Dehghani-Firoozabadi, F. Shamsi, Maleknaz Baghianimoghaddam, M. Dargahi, Pouria Yazian, S. Mojahed (2015)
The Most Common Type of HPV in Women with Atypical Squamous Cell of Undetermined Significance (ASCUS) in Pap Smear in Iran-YazdInternational Journal of Biomedical Science : IJBS, 11
Hui-Hui Xu, A. Lin, Yahong Chen, Shan-Shan Dong, W. Shi, Jia Yu, Wei-Hua Yan (2017)
Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general populationBMJ Open, 7
E. González-Bosquet, S. Fernández, S. Sabra, J. Lailla (2017)
Negative HPV testing among patients with biopsy‐proven cervical intraepithelial neoplasia grade 2/3 or cervical cancerInternational Journal of Gynecology & Obstetrics, 136
S. Barron, R. Austin, Zaibo Li, Chengquan Zhao (2015)
Follow-up outcomes in a large cohort of patients with HPV-negative LSIL cervical screening test results.American journal of clinical pathology, 143 4
Cornelis Huijsmans, Willemina Geurts‐Giele, Cindy Leeijen, Hendrikus Hazenberg, Jenneke Beek, Carola Wild, J. Linden, A. Brule (2016)
HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflowsBMC Cancer, 16
L. Shulman (2011)
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trialYearbook of Obstetrics, Gynecology and Women's Health, 2011
J. Patnick (2003)
Review of recommendations on cervical cancer screening in the European Union.Minerva ginecologica, 55 4
L. Markowitz, E. Dunne, Monal Saraiya, H. Chesson, Curtis Cr, Julianne Gee, J. Bocchini, E. Unger (2014)
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 63 RR-05
H. Katki, M. Schiffman, P. Castle, B. Fetterman, N. Poitras, T. Lorey, L. Cheung, Tina Raine-Bennett, J. Gage, W. Kinney (2013)
Five-Year Risks of CIN 2+ and CIN 3+ Among Women With HPV-Positive and HPV-Negative LSIL Pap ResultsJournal of Lower Genital Tract Disease, 17
M. Arbyn, G. Ronco, A. Anttila, C. Meijer, M. Poljak, G. Ogilvie, G. Koliopoulos, P. Nauclér, R. Sankaranarayanan, J. Peto (2012)
Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.Vaccine, 30 Suppl 5
Sanjay Gupta, P. Sodhani (2012)
Reducing “atypical squamous cells” overdiagnosis on cervicovaginal smears by diligent cytology screeningDiagnostic Cytopathology, 40
K. Alanen, L. Elit, Patricia Molinaro, C. McLachlin (1998)
Assessment of cytologic follow‐up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesionsCancer Cytopathology, 84
J. Crow (2012)
HPV: The global burdenNature, 488
M. Mousa, S. Al-amri, A. Degnah, A. Tolah, H. Abduljabbar, A. Oraif, H. Abduljabbar, A. Mirza, E. Azhar, A. Hashem (2019)
Prevalence of human papillomavirus in Jeddah, Saudi ArabiaAnnals of Saudi Medicine, 39
A. Moscicki, Yifei Ma, S. Farhat, T. Darragh, M. Pawlita, D. Galloway, S. Shiboski (2013)
Redetection of cervical human papillomavirus type 16 (HPV16) in women with a history of HPV16.The Journal of infectious diseases, 208 3
C. Bergeron, M. Doeberitz (2016)
The Role of Cytology in the 21st Century: The Integration of Cells and MoleculesActa Cytologica, 60
G. Clifford, Jennifer Smith, M. Plummer, N. Muñoz, S. Franceschi (2003)
Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 88
Stell Patadji, Zaibo Li, D. Pradhan, Chengquan Zhao (2017)
Significance of high‐risk HPV detection in women with atypical glandular cells on Pap testing: Analysis of 1857 cases from an academic institutionCancer Cytopathology, 125
Emiko Petrosky, J. Bocchini, S. Hariri, H. Chesson, C. Curtis, M. Saraiya, E. Unger, L. Markowitz (2015)
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization PracticesMorbidity and Mortality Weekly Report, 64
R. Al-Awadhi, W. Chehadeh, K. Kapila (2011)
Prevalence of human papillomavirus among women with normal cervical cytology in KuwaitJournal of Medical Virology, 83
PhD Curry (2018)
Screening for Cervical Cancer US Preventive Services Task Force Recommendation Statement
(2016)
Practice Bulletin No. 168 Summary: Cervical Cancer Screening and PreventionObstetrics & Gynecology, 128
D. Forman, Catherine Martel, C. Lacey, I. Soerjomataram, J. Lortet-Tieulent, L. Bruni, J. Vignat, J. Ferlay, F. Bray, M. Plummer, S. Franceschi (2012)
Global burden of human papillomavirus and related diseases.Vaccine, 30 Suppl 5
N. Anfinan (2019)
Physician’s knowledge and opinions on human papillomavirus vaccination: a cross-sectional study, Saudi ArabiaBMC Health Services Research, 19
S. Syrjänen, K. Syrjänen (2019)
HPV in Head and Neck Carcinomas: Different HPV Profiles in Oropharyngeal Carcinomas – Why?Acta Cytologica, 63
B. Serrano, M. Brotons, F. Bosch, L. Bruni (2017)
Epidemiology and burden of HPV-related disease.Best practice & research. Clinical obstetrics & gynaecology, 47
(2014)
Efficacy of HPVbased screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
K. Leite, Ruan Pimenta, Juliana Canavez, F. Canavez, F. Souza, Ligia Vara, C. Estivallet, L. Câmara-Lopes (2020)
HPV Genotype Prevalence and Success of Vaccination to Prevent Cervical CancerActa Cytologica, 64
Xuelian Zhao, Shuang Zhao, Shangying Hu, Kevin Zhao, Qian Zhang, Xun Zhang, Q. Pan, F. Zhao (2018)
Role of Human Papillomavirus DNA Load in Predicting the Long-term Risk of Cervical Cancer: A 15-Year Prospective Cohort Study in ChinaThe Journal of Infectious Diseases, 219
Geilson Oliveira, Judite Oliveira, R. Eleutério, Rita Barbosa, Paulo Almeida, José Jr (2018)
Atypical Squamous Cells: Cytopathological Findings and Correlation with HPV Genotype and HistopathologyActa Cytologica, 62
Tong Li, Yan Li, Guojian Yang, P. Shi, Xiaoyan Sun, Yu Yang, Ying-Ying Li, Yang Liu (2016)
Diagnostic value of combination of HPV testing and cytology as compared to isolated cytology in screening cervical cancer: A meta-analysis.Journal of cancer research and therapeutics, 12 1
Fatma Beyazıt, F. Sılan, M. Gencer, Buket Aydın, B. Paksoy, M. Unsal, O. Ozdemır (2018)
The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology.Ginekologia polska, 89 2
L. Bruni, Mireia Díaz, X. Castellsagué, E. Ferrer, F. Bosch, S. Sanjosé (2010)
Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.The Journal of infectious diseases, 202 12
Hala Yousif, A. Albasri, Mariam Alshanqite, H. Missawi (2019)
Histopathological Patterns and Characteristics of Abnormal Cervical Smear in Madinah Region of Saudi ArabiaAsian Pacific Journal of Cancer Prevention : APJCP, 20
Catherine Martel, M. Plummer, J. Vignat, S. Franceschi (2017)
Worldwide burden of cancer attributable to HPV by site, country and HPV typeInternational Journal of Cancer, 141
L. Madom, L. Boardman (2005)
HPV testing and cervical cancer screening: recommendations and practice patterns.Medicine and health, Rhode Island, 88 10
A. Rizzo, S. Feldman (2018)
Update on primary HPV screening for cervical cancer prevention.Current problems in cancer, 42 5
(2004)
The Bethesda system for reporting cervical cytology : definitions, criteria, and explanatory notes
K. Syrjänen (2011)
Persistent high-risk human papillomavirus (HPV) infections as surrogate endpoints of progressive cervical disease. Potential new endpoint for efficacy studies with new-generation (non-HPV 16/18) prophylactic HPV vaccines.European journal of gynaecological oncology, 32 1
S. Sanjosé, Mireia Díaz, X. Castellsagué, G. Clifford, L. Bruni, N. Muñoz, F. Bosch (2007)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis.The Lancet. Infectious diseases, 7 7
G. Alsbeih (2014)
HPV Infection in Cervical and Other Cancers in Saudi Arabia: Implication for Prevention and VaccinationFrontiers in Oncology, 4
Baowen Zheng, Huaitao Yang, Zaibo Li, Guijian Wei, Jia You, Xiaoman Liang, Chengquan Zhao (2017)
HPV test results and histological follow-up results of patients with LSIL Cervical Cytology from the Largest CAP-certified laboratory in ChinaJournal of Cancer, 8
Sarah Hoffman, Tam Le, A. Lockhart, A. Sanusi, L. Santo, Meagan Davis, Dana McKinney, Meagan Brown, C. Poole, C. Willame, Jennifer Smith (2017)
Patterns of persistent HPV infection after treatment for cervical intraepithelial neoplasia (CIN): A systematic reviewInternational Journal of Cancer, 141
J. Jordan, M. Arbyn, P. Martin-Hirsch, U. Schenck, J. Baldauf, D. Silva, A. Anttila, P. Nieminen, W. Prendiville (2008)
European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1Cytopathology, 19
Introduction: High-risk human papillomavirus (HR HPV) is found to be responsible for 4.5% of cancer in general, primarily cervical cancer. We aim here to highlight the prevalence and genotypes of HR HPV and correlate its association with Pap tests’ results, which are still not well known in the Eastern Province of Saudi Arabia. Methods: Over 7 years (2013–2019), the results of 164 Saudi women coinvestigated for HR HPV along with Pap tests were collected from the archive of King Fahd University Hospital. Only women who had atypical squamous cells of undetermined significance (ASCUS) on the Pap test and those at elevated risk of infection were cotested for HR HPV; otherwise, the Pap test was the only screening modality for cervical cancer. Data were organized and statistically analyzed using IBM SPSS v26. Results: Out of 164 Saudi women, 14.5% (n = 24/164) showed positive results for HR HPV (8 patients had HPV16 and 2 had both HPV16 and HPV18/45, while the remaining 14 had other HR HPV); among them, 41.5% (n = 10/24) had an abnormal Pap test (5 ASCUS and 5 LSIL), while 58.5% (n = 14/24) had a negative Pap test. On the other hand, 21% (n = 35/164) of patients, in the study, had an abnormal Pap test (24 ASCUS, 8 low-grade squamous intraepithelial lesion [LSIL], and 3 atypical glandular cell [AGC]). In 80% (n = 19/24) of ASCUS cases, HR HPV was not detected; however, 20% (n = 5/24) were positive for other HR HPV. Concerning LSIL cases, 62.5% (n = 5/8) were positive for HR HPV (1 case showed HPV16 and HPV18/45, 2 cases showed HPV16, and 2 cases showed other HR HPV), while in the remaining 37.5% (n = 3/8) LSIL cases, HR HPV was negative; similarly, all AGC cases were negative for HR HPV. Statistical analysis showed a significant correlation between HPV status and Pap test findings (p value <0.001). Discussion/Conclusion: HR HPV frequency and genotype distribution, in this study, might reflect a different regional infection pattern. The high association of HR HPV with negative cytology emphasizes the need to add the HR HPV test to screening modalities of cervix cancer.
Acta Cytologica – Karger
Published: Jan 1, 2021
Keywords: Cervical cancer; Cancer screening; Pap test; Human papillomavirus infections; Papillomavirus vaccines; Papillomavirus genotypes
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.